Home > Healthcare & Medical Devices > Pet Cancer Therapeutics Market > Table of Contents

Pet Cancer Therapeutics Market Size By Therapy (Chemotherapy, Immunotherapy, Targeted Therapy, Combination Therapy), By Route of Administration (Oral, Injection), By Species (Dogs, Cats), By Application (Lymphoma, Mast Cell Cancer, Melanoma, Mammary and Squamous Cell Cancer), Industry Analysis Report, Regional Outlook, Growth Potential, COVID-19 Impact Analysis, Price Trends, Competitive Market Share & Forecast, 2022 – 2030

  • Report ID: GMI2017
  • Published Date: Aug 2022
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1    Market definitions

1.2    Base estimates and working

1.3    Forecast parameters

1.4    Data validation

1.5    Data sources

1.5.1    Secondary

1.5.1.1   Paid sources

1.5.1.2   Unpaid sources

1.5.2    Primary

Chapter 2   Executive Summary

2.1    Pet cancer therapeutics industry 360° synopsis, 2017 - 2030

2.1.1    Business trends

2.1.2    Therapy trends

2.1.3    Route of administration trends

2.1.4    Species trends

2.1.5    Applications trends

2.1.6    Regional trends

Chapter 3   Pet Cancer Therapeutics Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2017 - 2030 (USD Million)

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1   Rising prevalence of pet cancer

3.3.1.2   Growing awareness among pet owners regarding pet diseases

3.3.1.3   Increasing pet care expenditure

3.3.1.4   Technological advancements in pet cancer therapeutics including cancer immunotherapy

3.3.1.5   High medical unmet need and strong potential

3.3.2    Industry pitfalls & challenges

3.3.2.1   Side effects associated with pet cancer therapeutics

3.3.2.2   Lack of veterinary oncologists

3.4    Growth potential analysis

3.4.1    By therapy

3.4.2    By route of administration

3.4.3    By species

3.4.4    By application

3.5    COVID- 19 impact analysis

3.6    Product pipeline analysis

3.7    Regulatory landscape

3.7.1    U.S.

3.7.2    European Union

3.7.3    Brazil

3.7.4    Australia

3.7.5    India

3.8    Porter's analysis

3.9    Competitive landscape, 2021

3.9.1    Company matrix analysis, 2021

3.10    PESTLE Analysis

Chapter 4   Pet Cancer Therapeutics Market, By Therapy

4.1    Key segment trends

4.2    Chemotherapy

4.2.1    Market size, by region, 2017 - 2030 (USD Million)

4.3    Immunotherapy

4.3.1    Market size, by region, 2017 - 2030 (USD Million)

4.4    Targeted therapy

4.4.1    Market size, by region, 2017 - 2030 (USD Million)

4.5    Combination therapy

4.5.1    Market size, by region, 2017 - 2030 (USD Million)

Chapter 5   Pet Cancer Therapeutics Market, By Route of Administration

5.1    Key segment trends

5.2    Oral

5.2.1    Market size, by region, 2017 - 2030 (USD Million)

5.3    Injection

5.3.1    Market size, by region, 2017 - 2030 (USD Million)

Chapter 6   Pet Cancer Therapeutics Market, By Species

6.1    Key segment trends

6.2    Dogs

6.2.1    Market size, by region, 2017 - 2030 (USD Million)

6.3    Cats

6.3.1    Market size, by region, 2017 - 2030 (USD Million)

Chapter 7   Pet Cancer Therapeutics Market, By Application

7.1    Key segment trends

7.2    Lymphoma

7.2.1    Market size, by region, 2017 - 2030 (USD Million)

7.3    Mast cell cancer

7.3.1    Market size, by region, 2017 - 2030 (USD Million)

7.4    Melanoma

7.4.1    Market size, by region, 2017 - 2030 (USD Million)

7.5    Mammary and squamous cell cancer

7.5.1    Market size, by region, 2017 - 2030 (USD Million)

7.6    Others

7.6.1    Market size, by region, 2017 - 2030 (USD Million)

Chapter 8   Pet Cancer Therapeutics Market, By Region

8.1    Key regional trends

8.2    North America

8.2.1    Market size, by country, 2017 - 2030 (USD Million)

8.2.2    Market size, by therapy, 2017 - 2030 (USD Million)

8.2.3    Market size, by route of administration, 2017 - 2030 (USD Million)

8.2.4    Market size, by species, 2017 - 2030 (USD Million)

8.2.5    Market size, by application, 2017 - 2030 (USD Million)

8.2.6    U.S.

8.2.6.1   Market size, by therapy, 2017 - 2030 (USD Million)

8.2.6.2   Market size, by route of administration, 2017 - 2030 (USD Million)

8.2.6.3   Market size, by species, 2017 - 2030 (USD Million)

8.2.6.4   Market size, by application, 2017 - 2030 (USD Million)

8.2.7    Canada

8.2.7.1   Market size, by therapy, 2017 - 2030 (USD Million)

8.2.7.2   Market size, by route of administration, 2017 - 2030 (USD Million)

8.2.7.3   Market size, by species, 2017 - 2030 (USD Million)

8.2.7.4   Market size, by application, 2017 - 2030 (USD Million)

8.3    Europe

8.3.1    Market size, by country, 2017 - 2030 (USD Million)

8.3.2    Market size, by therapy, 2017 - 2030 (USD Million)

8.3.3    Market size, by route of administration, 2017 - 2030 (USD Million)

8.3.4    Market size, by species, 2017 - 2030 (USD Million)

8.3.5    Market size, by application, 2017 - 2030 (USD Million)

8.3.6    Germany

8.3.6.1   Market size, by therapy, 2017 - 2030 (USD Million)

8.3.6.2   Market size, by route of administration, 2017 - 2030 (USD Million)

8.3.6.3   Market size, by species, 2017 - 2030 (USD Million)

8.3.6.4   Market size, by application, 2017 - 2030 (USD Million)

8.3.7    UK

8.3.7.1   Market size, by therapy, 2017 - 2030 (USD Million)

8.3.7.2   Market size, by route of administration, 2017 - 2030 (USD Million)

8.3.7.3   Market size, by species, 2017 - 2030 (USD Million)

8.3.7.4   Market size, by application, 2017 - 2030 (USD Million)

8.3.8    France

8.3.8.1   Market size, by therapy, 2017 - 2030 (USD Million)

8.3.8.2   Market size, by route of administration, 2017 - 2030 (USD Million)

8.3.8.3   Market size, by species, 2017 - 2030 (USD Million)

8.3.8.4   Market size, by application, 2017 - 2030 (USD Million)

8.3.9    Spain

8.3.9.1   Market size, by therapy, 2017 - 2030 (USD Million)

8.3.9.2   Market size, by route of administration, 2017 - 2030 (USD Million)

8.3.9.3   Market size, by species, 2017 - 2030 (USD Million)

8.3.9.4   Market size, by application, 2017 - 2030 (USD Million)

8.3.10    Italy

8.3.10.1    Market size, by therapy, 2017 - 2030 (USD Million)

8.3.10.2    Market size, by route of administration, 2017 - 2030 (USD Million)

8.3.10.3    Market size, by species, 2017 - 2030 (USD Million)

8.3.10.4    Market size, by application, 2017 - 2030 (USD Million)

8.4    Asia Pacific

8.4.1    Market size, by country, 2017 - 2030 (USD Million)

8.4.2    Market size, by therapy, 2017 - 2030 (USD Million)

8.4.3    Market size, by route of administration, 2017 - 2030 (USD Million)

8.4.4    Market size, by species, 2017 - 2030 (USD Million)

8.4.5    Market size, by application, 2017 - 2030 (USD Million)

8.4.6    China

8.4.6.1   Market size, by therapy, 2017 - 2030 (USD Million)

8.4.6.2   Market size, by route of administration, 2017 - 2030 (USD Million)

8.4.6.3   Market size, by species, 2017 - 2030 (USD Million)

8.4.6.4   Market size, by application, 2017 - 2030 (USD Million)

8.4.7    Japan

8.4.7.1   Market size, by therapy, 2017 - 2030 (USD Million)

8.4.7.2   Market size, by route of administration, 2017 - 2030 (USD Million)

8.4.7.3   Market size, by species, 2017 - 2030 (USD Million)

8.4.7.4   Market size, by application, 2017 - 2030 (USD Million)

8.4.8    India

8.4.8.1   Market size, by therapy, 2017 - 2030 (USD Million)

8.4.8.2   Market size, by route of administration, 2017 - 2030 (USD Million)

8.4.8.3   Market size, by species, 2017 - 2030 (USD Million)

8.4.8.4   Market size, by application, 2017 - 2030 (USD Million)

8.4.9    Australia

8.4.9.1   Market size, by therapy, 2017 - 2030 (USD Million)

8.4.9.2   Market size, by route of administration, 2017 - 2030 (USD Million)

8.4.9.3   Market size, by species, 2017 - 2030 (USD Million)

8.4.9.4   Market size, by application, 2017 - 2030 (USD Million)

8.5    Latin America

8.5.1    Market size, by country, 2017 - 2030 (USD Million)

8.5.2    Market size, by therapy, 2017 - 2030 (USD Million)

8.5.3    Market size, by route of administration, 2017 - 2030 (USD Million)

8.5.4    Market size, by species, 2017 - 2030 (USD Million)

8.5.5    Market size, by application, 2017 - 2030 (USD Million)

8.5.6    Brazil

8.5.6.1   Market size, by therapy, 2017 - 2030 (USD Million)

8.5.6.2   Market size, by route of administration, 2017 - 2030 (USD Million)

8.5.6.3   Market size, by species, 2017 - 2030 (USD Million)

8.5.6.4   Market size, by application, 2017 - 2030 (USD Million)

8.5.7    Mexico

8.5.7.1   Market size, by therapy, 2017 - 2030 (USD Million)

8.5.7.2   Market size, by route of administration, 2017 - 2030 (USD Million)

8.5.7.3   Market size, by species, 2017 - 2030 (USD Million)

8.5.7.4   Market size, by application, 2017 - 2030 (USD Million)

Chapter 9   Company Profiles

9.1    Competitive dashboard, 2021

9.2    Zoetis, Inc.

9.2.1    Business Overview

9.2.2    Financial Data

9.2.3    Product Landscape

9.2.4    Strategic Outlook

9.2.5    SWOT Analysis

9.3    Elanco Animal Health

9.3.1    Business Overview

9.3.2    Financial Data

9.3.3    Product Landscape

9.3.4    Strategic Outlook

9.3.5    SWOT Analysis

9.4    Boehringer Ingelheim International GmbH

9.4.1    Business Overview

9.4.2    Financial Data

9.4.3    Product Landscape

9.4.4    Strategic Outlook

9.4.5    SWOT Analysis

9.5    Dechra Pharmaceuticals

9.5.1    Business Overview

9.5.2    Financial Data

9.5.3    Product Landscape

9.5.4    Strategic Outlook

9.5.5    SWOT Analysis

9.6    AB Science

9.6.1    Business Overview

9.6.2    Financial Data

9.6.3    Product Landscape

9.6.4    Strategic Outlook

9.6.5    SWOT Analysis

9.7    Qbiotics

9.7.1    Business Overview

9.7.2    Financial Data

9.7.3    Product Landscape

9.7.4    Strategic Outlook

9.7.5    SWOT Analysis

9.8    NovaVive, Inc.

9.8.1    Business Overview

9.8.2    Financial Data

9.8.3    Product Landscape

9.8.4    Strategic Outlook

9.8.5    SWOT Analysis

9.9    ELIAS Animal Health

9.9.1    Business Overview

9.9.2    Financial Data

9.9.3    Product Landscape

9.9.4    Strategic Outlook

9.9.5    SWOT Analysis

   

Data Tables

TABLE 1    Global pet cancer therapeutics market, 2017 - 2021 (USD Million)

TABLE 2    Global pet cancer therapeutics market, 2022 – 2030 (USD Million)

TABLE 3    Global pet cancer therapeutics market, by therapy, 2017 - 2021 (USD Million)

TABLE 4    Global pet cancer therapeutics market, by therapy, 2022 – 2030 (USD Million)

TABLE 5    Global pet cancer therapeutics market, by route of administration, 2017 - 2021 (USD Million)

TABLE 6    Global pet cancer therapeutics market, by route of administration, 2022 – 2030 (USD Million)

TABLE 7    Global pet cancer therapeutics market, by species, 2017 - 2021 (USD Million)

TABLE 8    Global pet cancer therapeutics market, by species, 2022 – 2030 (USD Million)

TABLE 9    Global pet cancer therapeutics market, by application, 2017 - 2021 (USD Million)

TABLE 10    Global pet cancer therapeutics market, by application, 2022 – 2030 (USD Million)

TABLE 11    Global pet cancer therapeutics market, by region, 2017 - 2021 (USD Million)

TABLE 12    Global pet cancer therapeutics market, by region, 2022 – 2030 (USD Million)

TABLE 13    Industry impact forces

TABLE 14    Chemotherapy market, by region, 2017 - 2021, (USD Million)

TABLE 15    Chemotherapy market, by region, 2022 - 2030, (USD Million)

TABLE 16    Immunotherapy market, by region, 2017 - 2021, (USD Million)

TABLE 17    Immunotherapy market, by region, 2022 - 2030, (USD Million)

TABLE 18    Targeted therapy market, by region, 2017 - 2021, (USD Million)

TABLE 19    Targeted therapy market, by region, 2022 - 2030, (USD Million)

TABLE 20    Combined therapy market, by region, 2017 - 2021, (USD Million)

TABLE 21    Combined therapy market, by region, 2022 - 2030, (USD Million)

TABLE 22    Oral market, by region, 2017 - 2021, (USD Million)

TABLE 23    Oral market, by region, 2022 - 2030, (USD Million)

TABLE 24    Injection market, by region, 2017 - 2021, (USD Million)

TABLE 25    Injection market, by region, 2022 - 2030, (USD Million)

TABLE 26    Dogs market, by region, 2017 - 2021, (USD Million)

TABLE 27    Dogs market, by region, 2022 – 2030, (USD Million)

TABLE 28    Cats market, by region, 2017 - 2021, (USD Million)

TABLE 29    Cats market, by region, 2022 - 2030, (USD Million)

TABLE 30    Lymphoma market, by region, 2017 - 2021, (USD Million)

TABLE 31    Lymphoma market, by region, 2022 - 2030, (USD Million)

TABLE 32    Mast cell cancer market, by region, 2017 - 2021, (USD Million)

TABLE 33    Mast cell cancer market, by region, 2022 - 2030, (USD Million)

TABLE 34    Melanoma market, by region, 2017 - 2021, (USD Million)

TABLE 35    Melanoma market, by region, 2022 - 2030, (USD Million)

TABLE 36    Mammary and squamous cell cancer market, by region, 2017 - 2021, (USD Million)

TABLE 37    Mammary and squamous cell cancer market, by region, 2022 - 2030, (USD Million)

TABLE 38    Others market, by region, 2017 - 2021, (USD Million)

TABLE 39    Others market, by region, 2022 - 2030, (USD Million)

TABLE 40    North America pet cancer therapeutics market, by country, 2017-2021, (USD Million)

TABLE 41    North America pet cancer therapeutics market, by country, 2022-2030, (USD Million)

TABLE 42    North America pet cancer therapeutics market, by therapy, 2017-2021, (USD Million)

TABLE 43    North America pet cancer therapeutics market, by therapy, 2022-2030, (USD Million)

TABLE 44    North America pet cancer therapeutics market, by route of administration, 2017-2021, (USD Million)

TABLE 45    North America pet cancer therapeutics market, by route of administration, 2022-2030, (USD Million)

TABLE 46    North America pet cancer therapeutics market, by species, 2017-2021, (USD Million)

TABLE 47    North America pet cancer therapeutics market, by species, 2022-2030, (USD Million)

TABLE 48    North America pet cancer therapeutics market, by application, 2017-2021, (USD Million)

TABLE 49    North America pet cancer therapeutics market, by application, 2022-2030, (USD Million)

TABLE 50    U.S. pet cancer therapeutics market, by therapy, 2017-2021, (USD Million)

TABLE 51    U.S. pet cancer therapeutics market, by therapy, 2022-2030, (USD Million)

TABLE 52    U.S. pet cancer therapeutics market, by route of administration, 2017-2021, (USD Million)

TABLE 53    U.S. pet cancer therapeutics market, by route of administration, 2022-2030, (USD Million)

TABLE 54    U.S. pet cancer therapeutics market, by species, 2017-2021, (USD Million)

TABLE 55    U.S. pet cancer therapeutics market, by species, 2022-2030, (USD Million)

TABLE 56    U.S. pet cancer therapeutics market, by application, 2017-2021, (USD Million)

TABLE 57    U.S. pet cancer therapeutics market, by application, 2022-2030, (USD Million)

TABLE 58    Canada pet cancer therapeutics market, by therapy, 2017-2021, (USD Million)

TABLE 59    Canada pet cancer therapeutics market, by therapy, 2022-2030, (USD Million)

TABLE 60    Canada pet cancer therapeutics market, by route of administration, 2017-2021, (USD Million)

TABLE 61    Canada pet cancer therapeutics market, by route of administration, 2022-2030, (USD Million)

TABLE 62    Canada pet cancer therapeutics market, by species, 2017-2021, (USD Million)

TABLE 63    Canada pet cancer therapeutics market, by species, 2022-2030, (USD Million)

TABLE 64    Canada pet cancer therapeutics market, by application, 2017-2021, (USD Million)

TABLE 65    Canada pet cancer therapeutics market, by application, 2022-2030, (USD Million)

TABLE 66    Europe pet cancer therapeutics market, by country, 2017-2021, (USD Million)

TABLE 67    Europe pet cancer therapeutics market, by country, 2022-2030, (USD Million)

TABLE 68    Europe pet cancer therapeutics market, by therapy, 2017-2021, (USD Million)

TABLE 69    Europe pet cancer therapeutics market, by therapy, 2022-2030, (USD Million)

TABLE 70    Europe pet cancer therapeutics market, by route of administration, 2017-2021, (USD Million)

TABLE 71    Europe pet cancer therapeutics market, by route of administration, 2022-2030, (USD Million)

TABLE 72    Europe pet cancer therapeutics market, by species, 2017-2021, (USD Million)

TABLE 73    Europe pet cancer therapeutics market, by species, 2022-2030, (USD Million)

TABLE 74    Europe pet cancer therapeutics market, by application, 2017-2021, (USD Million)

TABLE 75    Europe pet cancer therapeutics market, by application, 2022-2030, (USD Million)

TABLE 76    Germany pet cancer therapeutics market, by therapy, 2017-2021, (USD Million)

TABLE 77    Germany pet cancer therapeutics market, by therapy, 2022-2030, (USD Million)

TABLE 78    Germany pet cancer therapeutics market, by route of administration, 2017-2021, (USD Million)

TABLE 79    Germany pet cancer therapeutics market, by route of administration, 2022-2030, (USD Million)

TABLE 80    Germany pet cancer therapeutics market, by species, 2017-2021, (USD Million)

TABLE 81    Germany pet cancer therapeutics market, by species, 2022-2030, (USD Million)

TABLE 82    Germany pet cancer therapeutics market, by application, 2017-2021, (USD Million)

TABLE 83    Germany pet cancer therapeutics market, by application, 2022-2030, (USD Million)

TABLE 84    UK pet cancer therapeutics market, by therapy, 2017-2021, (USD Million)

TABLE 85    UK pet cancer therapeutics market, by therapy, 2022-2030, (USD Million)

TABLE 86    UK pet cancer therapeutics market, by route of administration, 2017-2021, (USD Million)

TABLE 87    UK pet cancer therapeutics market, by route of administration, 2022-2030, (USD Million)

TABLE 88    UK pet cancer therapeutics market, by species, 2017-2021, (USD Million)

TABLE 89    UK pet cancer therapeutics market, by species, 2022-2030, (USD Million)

TABLE 90    UK pet cancer therapeutics market, by application, 2017-2021, (USD Million)

TABLE 91    UK pet cancer therapeutics market, by application, 2022-2030, (USD Million)

TABLE 92    France pet cancer therapeutics market, by therapy, 2017-2021, (USD Million)

TABLE 93    France pet cancer therapeutics market, by therapy, 2022-2030, (USD Million)

TABLE 94    France pet cancer therapeutics market, by route of administration, 2017-2021, (USD Million)

TABLE 95    France pet cancer therapeutics market, by route of administration, 2022-2030, (USD Million)

TABLE 96    France pet cancer therapeutics market, by species, 2017-2021, (USD Million)

TABLE 97    France pet cancer therapeutics market, by species, 2022-2030, (USD Million)

TABLE 98    France pet cancer therapeutics market, by application, 2017-2021, (USD Million)

TABLE 99    France pet cancer therapeutics market, by application, 2022-2030, (USD Million)

TABLE 100    Spain pet cancer therapeutics market, by therapy, 2017-2021, (USD Million)

TABLE 101    Spain pet cancer therapeutics market, by therapy, 2022-2030, (USD Million)

TABLE 102    Spain pet cancer therapeutics market, by route of administration, 2017-2021, (USD Million)

TABLE 103    Spain pet cancer therapeutics market, by route of administration, 2022-2030, (USD Million)

TABLE 104    Spain pet cancer therapeutics market, by species, 2017-2021, (USD Million)

TABLE 105    Spain pet cancer therapeutics market, by species, 2022-2030, (USD Million)

TABLE 106    Spain pet cancer therapeutics market, by application, 2017-2021, (USD Million)

TABLE 107    Spain pet cancer therapeutics market, by application, 2022-2030, (USD Million)

TABLE 108    Italy pet cancer therapeutics market, by therapy, 2017-2021, (USD Million)

TABLE 109    Italy pet cancer therapeutics market, by therapy, 2022-2030, (USD Million)

TABLE 110    Italy pet cancer therapeutics market, by route of administration, 2017-2021, (USD Million)

TABLE 111    Italy pet cancer therapeutics market, by route of administration, 2022-2030, (USD Million)

TABLE 112    Italy pet cancer therapeutics market, by species, 2017-2021, (USD Million)

TABLE 113    Italy pet cancer therapeutics market, by species, 2022-2030, (USD Million)

TABLE 114    Italy pet cancer therapeutics market, by application, 2017-2021, (USD Million)

TABLE 115    Italy pet cancer therapeutics market, by application, 2022-2030, (USD Million)

TABLE 116    Asia Pacific pet cancer therapeutics market, by country, 2017-2021, (USD Million)

TABLE 117    Asia Pacific pet cancer therapeutics market, by country, 2022-2030, (USD Million)

TABLE 118    Asia Pacific pet cancer therapeutics market, by therapy, 2017-2021, (USD Million)

TABLE 119    Asia Pacific pet cancer therapeutics market, by therapy, 2022-2030, (USD Million)

TABLE 120    Asia Pacific pet cancer therapeutics market, by route of administration, 2017-2021, (USD Million)

TABLE 121    Asia Pacific pet cancer therapeutics market, by route of administration, 2022-2030, (USD Million)

TABLE 122    Asia Pacific pet cancer therapeutics market, by species, 2017-2021, (USD Million)

TABLE 123    Asia Pacific pet cancer therapeutics market, by species, 2022-2030, (USD Million)

TABLE 124    Asia Pacific pet cancer therapeutics market, by application, 2017-2021, (USD Million)

TABLE 125    Asia Pacific pet cancer therapeutics market, by application, 2022-2030, (USD Million)

TABLE 126    China pet cancer therapeutics market, by therapy, 2017-2021, (USD Million)

TABLE 127    China pet cancer therapeutics market, by therapy, 2022-2030, (USD Million)

TABLE 128    China pet cancer therapeutics market, by route of administration, 2017-2021, (USD Million)

TABLE 129    China pet cancer therapeutics market, by route of administration, 2022-2030, (USD Million)

TABLE 130    China pet cancer therapeutics market, by species, 2017-2021, (USD Million)

TABLE 131    China pet cancer therapeutics market, by species, 2022-2030, (USD Million)

TABLE 132    China pet cancer therapeutics market, by application, 2017-2021, (USD Million)

TABLE 133    China pet cancer therapeutics market, by application, 2022-2030, (USD Million)

TABLE 134    India pet cancer therapeutics market, by therapy, 2017-2021, (USD Million)

TABLE 135    India pet cancer therapeutics market, by therapy, 2022-2030, (USD Million)

TABLE 136    India pet cancer therapeutics market, by route of administration, 2017-2021, (USD Million)

TABLE 137    India pet cancer therapeutics market, by route of administration, 2022-2030, (USD Million)

TABLE 138    India pet cancer therapeutics market, by species, 2017-2021, (USD Million)

TABLE 139    India pet cancer therapeutics market, by species, 2022-2030, (USD Million)

TABLE 140    India pet cancer therapeutics market, by application, 2017-2021, (USD Million)

TABLE 141    India pet cancer therapeutics market, by application, 2022-2030, (USD Million)

TABLE 142    Japan pet cancer therapeutics market, by therapy, 2017-2021, (USD Million)

TABLE 143    Japan pet cancer therapeutics market, by therapy, 2022-2030, (USD Million)

TABLE 144    Japan pet cancer therapeutics market, by route of administration, 2017-2021, (USD Million)

TABLE 145    Japan pet cancer therapeutics market, by route of administration, 2022-2030, (USD Million)

TABLE 146    Japan pet cancer therapeutics market, by species, 2017-2021, (USD Million)

TABLE 147    Japan pet cancer therapeutics market, by species, 2022-2030, (USD Million)

TABLE 148    Japan pet cancer therapeutics market, by application, 2017-2021, (USD Million)

TABLE 149    Japan pet cancer therapeutics market, by application, 2022-2030, (USD Million)

TABLE 150    Australia pet cancer therapeutics market, by therapy, 2017-2021, (USD Million)

TABLE 151    Australia pet cancer therapeutics market, by therapy, 2022-2030, (USD Million)

TABLE 152    Australia pet cancer therapeutics market, by route of administration, 2017-2021, (USD Million)

TABLE 153    Australia pet cancer therapeutics market, by route of administration, 2022-2030, (USD Million)

TABLE 154    Australia pet cancer therapeutics market, by species, 2017-2021, (USD Million)

TABLE 155    Australia pet cancer therapeutics market, by species, 2022-2030, (USD Million)

TABLE 156    Australia pet cancer therapeutics market, by application, 2017-2021, (USD Million)

TABLE 157    Australia pet cancer therapeutics market, by application, 2022-2030, (USD Million)

TABLE 158    Latin America pet cancer therapeutics market, by country, 2017-2021, (USD Million)

TABLE 159    Latin America pet cancer therapeutics market, by country, 2022-2030, (USD Million)

TABLE 160    Latin America pet cancer therapeutics market, by therapy, 2017-2021, (USD Million)

TABLE 161    Latin America pet cancer therapeutics market, by therapy, 2022-2030, (USD Million)

TABLE 162    Latin America pet cancer therapeutics market, by route of administration, 2017-2021, (USD Million)

TABLE 163    Latin America pet cancer therapeutics market, by route of administration, 2022-2030, (USD Million)

TABLE 164    Latin America pet cancer therapeutics market, by species, 2017-2021, (USD Million)

TABLE 165    Latin America pet cancer therapeutics market, by species, 2022-2030, (USD Million)

TABLE 166    Latin America pet cancer therapeutics market, by application, 2017-2021, (USD Million)

TABLE 167    Latin America pet cancer therapeutics market, by application, 2022-2030, (USD Million)

TABLE 168    Brazil pet cancer therapeutics market, by therapy, 2017-2021, (USD Million)

TABLE 169    Brazil pet cancer therapeutics market, by therapy, 2022-2030, (USD Million)

TABLE 170    Brazil pet cancer therapeutics market, by route of administration, 2017-2021, (USD Million)

TABLE 171    Brazil pet cancer therapeutics market, by route of administration, 2022-2030, (USD Million)

TABLE 172    Brazil pet cancer therapeutics market, by species, 2017-2021, (USD Million)

TABLE 173    Brazil pet cancer therapeutics market, by species, 2022-2030, (USD Million)

TABLE 174    Brazil pet cancer therapeutics market, by application, 2017-2021, (USD Million)

TABLE 175    Brazil pet cancer therapeutics market, by application, 2022-2030, (USD Million)

TABLE 176    Mexico pet cancer therapeutics market, by therapy, 2017-2021, (USD Million)

TABLE 177    Mexico pet cancer therapeutics market, by therapy, 2022-2030, (USD Million)

TABLE 178    Mexico pet cancer therapeutics market, by route of administration, 2017-2021, (USD Million)

TABLE 179    Mexico pet cancer therapeutics market, by route of administration, 2022-2030, (USD Million)

TABLE 180    Mexico pet cancer therapeutics market, by species, 2017-2021, (USD Million)

TABLE 181    Mexico pet cancer therapeutics market, by species, 2022-2030, (USD Million)

TABLE 182    Mexico pet cancer therapeutics market, by application, 2017-2021, (USD Million)

TABLE 183    Mexico pet cancer therapeutics market, by application, 2022-2030, (USD Million)

 

Charts & Figures

FIG. 1    Top-down approach

FIG. 2    Breakdown of primary participants

FIG. 3    Pet cancer therapeutics market industry 360o synopsis, 2017 – 2030

FIG. 4    Industry segmentation

FIG. 5    Global pet cancer therapeutics, by region, 2017 - 2030 (USD Million)

FIG. 6    Growth potential analysis, by therapy

FIG. 7    Growth potential analysis, by route of administration

FIG. 8    Growth potential analysis, by species

FIG. 9    Growth potential analysis, by application

FIG. 10    Porter’s analysis

FIG. 11    Company matrix analysis, 2021

FIG. 12    PESTEL analysis

FIG. 13    Key segment trends, by therapy

FIG. 14    Key segment trends, by route of administration

FIG. 15    Key segment trends, by species

FIG. 16    Key segment trends, by application

FIG. 17    Key regional trends   

FIG. 18    Strategy dashboard, 2021
 

Authors: Sumant Ugalmugle, Rupali Swain

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies
Immediate Delivery Available

Premium Report Details

  • Base Year: 2021
  • Companies covered: 8
  • Tables & Figures: 201
  • Countries covered: 13
  • Pages: 145

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount